戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ontribute to the elevated numbers of OCLs in Paget's disease.
2 static and nonmetastatic prostate cancer and Paget's disease.
3                                     Juvenile Paget's disease, an autosomal recessive osteopathy, is c
4 ave been identified in four genes that cause Paget's disease and related syndromes.
5 asts are valuable for treating osteoporosis, Paget's disease, and inflammation of bone associated wit
6 ral" diseases such as multiple sclerosis and Paget's disease, and the controversy surrounding MV vacc
7                        Osteoclasts (OCLs) in Paget's disease are markedly increased in number and siz
8 protegerin deficiency could explain juvenile Paget's disease because osteoprotegerin suppresses bone
9  destruction in postmenopausal osteoporosis, Paget's disease, bone metastasis, and hypercalcemia of m
10                             Recognizing that Paget's disease can not only cause absent but also expan
11                                     Juvenile Paget's disease can result from osteoprotegerin deficien
12 as been used in therapy for osteoporosis and Paget's disease for decades, human calcitonin (hCT) form
13 ntly unrelated Navajo patients with juvenile Paget's disease for defects in the gene encoding osteopr
14                                              Paget's disease is characterized by highly localized are
15                                              Paget's disease is often asymptomatic but can be associa
16 ride therapy (n = 20) and patients with mild Paget's disease (n = 5).
17                                              Paget's disease of bone (PDB) is a common disorder chara
18                                              Paget's disease of bone (PDB) is a common disorder chara
19                                              Paget's disease of bone (PDB) is a common disorder with
20                                              Paget's disease of bone (PDB) is a common disorder with
21                                              Paget's disease of bone (PDB) is the second most common
22 of SQSTM1 occur in about10% of patients with Paget's disease of bone (PDB), but it is unclear whether
23   Patients with SQSTM1 mutations have severe Paget's disease of bone and a high degree of penetrance
24      Inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia (IBM
25      Inclusion body myopathy associated with Paget's disease of bone and frontotemporal dementia (IBM
26 ding p62 are commonly found in patients with Paget's disease of bone and largely cluster within the C
27                                              Paget's disease of bone is a common disease characterise
28                        Medical management of Paget's disease of bone is based on giving inhibitors of
29              We report a case of polyostotic Paget's disease of bone that caused an unusual pattern o
30  mutant that causes inclusion body myopathy, Paget's disease of bone, and frontotemporal dementia in
31  prevent the development of complications of Paget's disease of bone, and further work is needed to a
32 , including cancer-related hypercalcemia and Paget's disease of bone, studies have been initiated to
33 , including cancer-related hypercalcemia and Paget's disease of bone, studies were initiated to explo
34 e treatment of osteopenia, osteoporosis, and Paget's disease of bone.
35  are a common cause of familial and sporadic Paget's disease of bone.
36 eat osteoporosis in postmenopausal women and Paget's disease of bone.
37      Inclusion body myopathy associated with Paget's disease of the bone and fronto-temporal dementia
38 ted syndrome of inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia
39 ause inclusion body myopathy associated with Paget's disease of the bone and frontotemporal dementia
40 es that include inclusion body myopathy with Paget's disease of the bone and frontotemporal dementia,
41 n as inclusion body myopathy associated with Paget's disease of the bone and frontotemporal dementia.
42 n (VCP) cause inclusion body myopathy (IBM), Paget's disease of the bone, and frontotemporal dementia
43 ns are the cause of inclusion body myopathy, Paget's disease of the bone, and frontotemporal dementia
44 nclusion body myopathy (IBM) associated with Paget's disease of the bone, fronto-temporal dementia an
45 insonism, frontotemporal dementia, myopathy, Paget's disease, or a combination of these.
46 rugs used in the treatment of hypercalcemia, Paget's disease, osteoporosis, and malignancy.
47                                              Paget's disease (PD) is characterized by focal and drama
48                      This case suggests that Paget's disease should be considered as a diagnostic pos
49 ugs that treat osteoporosis, hypercalcaemia, Paget's disease, type II diabetes, and obesity and are b
50  role of MV in the abnormal OCL phenotype of Paget's disease, we transduced normal OCL precursors wit
51 e yields samples which permit a diagnosis of Paget's disease without surgical biopsy.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。